311 related articles for article (PubMed ID: 8825511)
1. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae.
Seleena P; Lee HL; Lecadet MM
J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511
[TBL] [Abstract][Full Text] [Related]
2. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae.
Thiéry I; Fouque F; Gaven B; Lagneau C
J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130
[TBL] [Abstract][Full Text] [Related]
3. A novel insecticidal serotype of Clostridium bifermentans.
Seleena P; Lee HL; Lecadet MM
J Am Mosq Control Assoc; 1997 Dec; 13(4):395-7. PubMed ID: 9474569
[TBL] [Abstract][Full Text] [Related]
4. Host range and selected factors influencing the mosquito larvicidal activity of the PG-14 isolate of Bacillus thuringiensis var. morrisoni.
Lacey LA; Lacey CM; Padua LE
J Am Mosq Control Assoc; 1988 Mar; 4(1):39-43. PubMed ID: 3193097
[TBL] [Abstract][Full Text] [Related]
5. An isolate of Bacillus circulans toxic to mosquito larvae.
Darriet F; Hougard JM
J Am Mosq Control Assoc; 2002 Mar; 18(1):65-7. PubMed ID: 11998934
[TBL] [Abstract][Full Text] [Related]
6. Insecticidal potency of bacterial species Bacillus thuringiensis SV2 and Serratia nematodiphila SV6 against larvae of mosquito species Aedes aegypti, Anopheles stephensi, and Culex quinquefasciatus.
Patil CD; Patil SV; Salunke BK; Salunkhe RB
Parasitol Res; 2012 May; 110(5):1841-7. PubMed ID: 22065062
[TBL] [Abstract][Full Text] [Related]
7. Bacillus thuringiensis serovar mogi (flagellar serotype 3a3b3d), a novel serogroup with a mosquitocidal activity.
Roh JY; Liu Q; Lee DW; Tao X; Wang Y; Shim HJ; Choi JY; Seo JB; Ohba M; Mizuki E; Je YH
J Invertebr Pathol; 2009 Nov; 102(3):266-8. PubMed ID: 19703461
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae.
Rettich F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232
[TBL] [Abstract][Full Text] [Related]
9. Comparative delta-endotoxins of Bacillus thuringiensis against mosquito vectors (Aedes aegypti and Culex pipiens).
Lonc E; Kucińska J; Rydzanicz K
Acta Microbiol Pol; 2003; 52(3):293-300. PubMed ID: 14743982
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of entomopathogenic bacteria against Aedes polynesiensis, the vector of lymphatic filariasis in French Polynesia.
Mercer DR; Nicolas L; Thiery I
J Am Mosq Control Assoc; 1995 Dec; 11(4):485-8. PubMed ID: 8825516
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioassays of Bacillus thuringiensis H-14 formulations against four species of mosquitoes in Malaysia.
Foo AE; Yap HH
Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):206-10. PubMed ID: 6128794
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and genotypic features of new autoagglutinating Bacillus thuringiensis strains.
Chaves JQ; Cavados CF; Rabinovitch L
J Invertebr Pathol; 2008 May; 98(1):85-92. PubMed ID: 18304571
[TBL] [Abstract][Full Text] [Related]
13. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid.
Yap HH; Lee YW; Zairi J
J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931
[TBL] [Abstract][Full Text] [Related]
14. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species.
Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD
J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266
[TBL] [Abstract][Full Text] [Related]
15. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
Mittal PK; Adak T; Batra CP
J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of the bioactivity of vegetative proteins extracted from Malaysian Bacillus thuringiensis isolates.
Ramasamy B; Nadarajah VD; Soong ZK; Lee HL; Mohammad SM
Trop Biomed; 2008 Apr; 25(1):64-74. PubMed ID: 18600206
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of Bacillus thuringiensis Cry4Ba and Cyt2Aa2 in Escherichia coli revealed high synergism against Aedes aegypti and Culex quinquefasciatus larvae.
Promdonkoy B; Promdonkoy P; Panyim S
FEMS Microbiol Lett; 2005 Nov; 252(1):121-6. PubMed ID: 16168580
[TBL] [Abstract][Full Text] [Related]
18. Integrated management of waste tire mosquitoes utilizing Mesocyclops longisetus (Copepoda: Cyclopidae), Bacillus thuringiensis var. israelensis, Bacillus sphaericus, and methoprene.
Tietze NS; Hester PG; Shaffer KR; Prescott SJ; Schreiber ET
J Am Mosq Control Assoc; 1994 Sep; 10(3):363-73. PubMed ID: 7807078
[TBL] [Abstract][Full Text] [Related]
19. Host range of Clostridium bifermentans serovar. malaysia, a mosquitocidal anaerobic bacterium.
Thiery I; Hamon S; Gaven B; De Barjac H
J Am Mosq Control Assoc; 1992 Sep; 8(3):272-7. PubMed ID: 1357087
[TBL] [Abstract][Full Text] [Related]
20. Laboratory and field efficacy of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus against Anopheles gambiae s.l. and Culex quinquefasciatus in Ouagadougou, Burkina Faso.
Majori G; Ali A; Sabatinelli G
J Am Mosq Control Assoc; 1987 Mar; 3(1):20-5. PubMed ID: 3504891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]